Serum protein electrophoresis (SPE) can show concomitant hypoalbuminemia and polyclonal increase in all gamma globulins (polyclonal gammopathy) in patients with chronic inflammation.
Patient education for chronic inflammation management emphasizes lifestyle modifications, specifically weight loss, regular exercise, smoking cessation, a healthy diet, and good sleep hygiene.
Granulomatous inflammation is a specific type of chronic inflammation characterized by distinct nodular lesions or granulomas formed by an aggregation of activated macrophages or epithelioid cells, usually surrounded by lymphocytes.
Chronic inflammation retains several features of acute inflammation, including vasodilation (expansion of blood vessels), increased blood flow, increased capillary permeability, and the migration of neutrophils into infected tissue through the capillary wall (diapedesis).
Untreated chronic inflammation generally carries a poor prognosis, with morbidity and mortality dependent on the specific causative mechanistic process.
The use of antibiotics, antacids, and NSAIDs should be minimized because they can harm the gut microbiome, causing inflammation in intestinal walls known as leaky gut, which releases toxins and triggers body-wide chronic inflammation.
The extent and effects of chronic inflammation vary based on the cause of the injury and the body's ability to repair and overcome the damage.
Chronic inflammation can arise from recurrent episodes of acute inflammation, though in some cases, such as tuberculosis and rheumatoid arthritis, it is an independent response rather than a sequel to acute inflammation.
Amyloidosis can result from underlying chronic inflammation and lead to severe renal complications.
Chronic inflammation progresses silently and is considered a major contributor to most chronic diseases, threatening individual health and longevity.
Chronic kidney disease (CKD) is characterized by low-grade inflammation, which leads to the retention of pro-inflammatory molecules in the blood and contributes to disease progression and mortality.
Chronic inflammation is characterized by the infiltration of primary inflammatory cells, specifically macrophages, lymphocytes, and plasma cells, into the tissue site.
Chronic inflammation is defined as a slow, long-term inflammatory process that lasts for prolonged periods of several months to years.
Limiting the consumption of inflammation-promoting foods such as sodas, refined carbohydrates, and fructose corn syrup is beneficial for reducing chronic inflammation.
To prevent chronic inflammation, individuals should avoid simple sugars, refined carbohydrates, high-glycemic foods, trans fats, and hydrogenated oils, while increasing consumption of whole grains, natural foods, vegetables, fruits (such as avocados and cherries), and fatty fish like salmon.
There are no highly effective laboratory measures to assess patients for chronic inflammation, and diagnoses are typically only undertaken when inflammation occurs in association with another medical condition.
High-sensitivity C-reactive protein (hsCRP) is not a specific marker for chronic inflammation because it is also elevated in acute inflammation resulting from recent injury or sickness.
Regular exercise helps control weight, decreases the risk of cardiovascular diseases, strengthens the heart, muscles, and bones, and helps prevent chronic inflammation.
In some cases, long-term anti-inflammatory medications are necessary to control chronic inflammation.
Chronic inflammation is a key factor causing almost all chronic degenerative diseases.
Chronic inflammation is a mechanistic process rather than a specific disease.
Autoimmune disorders cause chronic inflammation when the immune system recognizes normal body components as foreign antigens and attacks healthy tissue, leading to diseases such as rheumatoid arthritis and systemic lupus erythematosus.
Chronic inflammation can result from exposure to low levels of irritants or foreign materials that cannot be eliminated by enzymatic breakdown or phagocytosis, such as industrial chemicals or substances like silica dust that are inhaled over a long period.
Sleep disorders are an independent risk factor for chronic inflammation because individuals with irregular sleep schedules are more likely to experience chronic inflammation than consistent sleepers.
Diagnoses for chronic inflammation are only undertaken when the inflammation occurs in association with another medical condition, as there are no highly effective laboratory measures to assess patients for chronic inflammation.
Disease-specific morbidity and mortality in cases of chronic inflammation are dependent on the causative mechanistic process leading to the inflammation.
Inadequately treated rheumatoid arthritis, where chronic inflammation persists in the synovium, is associated with a worse prognosis and radiographic disease progression.
Chronic inflammation is associated with multiple diseases, including cardiovascular disease, diabetes, malignancy, autoimmune disease, and chronic hepatic and renal disease.
Atherosclerosis is a pro-inflammatory state characterized by chronic low-grade inflammation that increases the risk of cardiovascular events such as myocardial infarction and stroke.
The severity and effects of chronic inflammation are determined by the nature of the injury and the body's capacity to repair and overcome the resulting damage.
Physical and emotional stress are associated with the release of inflammatory cytokines and can cause sleep disorders, which are considered an independent risk factor for chronic inflammation.
Detecting pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), interleukin-6 (IL-6), and interleukin-8 (IL-8) is an expensive method that may identify specific factors causing chronic inflammation, though these assays are not standardized.
The prevalence of diseases associated with chronic inflammation is anticipated to increase persistently in the United States over the 30-year period following the publication of the StatPearls article.
In some cases of chronic inflammation, patients may require lifelong anti-inflammatory medications to control the condition.
Minimizing the intake of antibiotics, antacids, and NSAIDs is recommended to prevent chronic inflammation because these substances can harm the gut microbiome, causing inflammation in intestinal walls known as leaky gut, which releases toxins and triggers body-wide inflammation.
In chronic inflammation, infiltrating macrophages, lymphocytes, and plasma cells produce inflammatory cytokines, growth factors, and enzymes, which contribute to tissue damage progression and secondary repair processes such as fibrosis and granuloma formation.
Chronic inflammation in rheumatoid arthritis is induced in genetically susceptible hosts by environmental factors such as smoking and infections, leading to a systemic autoimmune response and local joint inflammation.
Obesity is a risk factor for chronic inflammation because fat tissue acts as an endocrine organ, secreting adipokines and inflammatory mediators, with body mass index being proportional to the amount of pro-inflammatory cytokines secreted, as exemplified by metabolic syndrome.
Clinicians can confirm or rule out most differential diagnoses for chronic inflammation using patient history, physical examination, and routine laboratory tests, including glucose, creatinine, liver function, serum protein electrophoresis, rheumatoid factor, complete blood count, and antinuclear antibodies.
Low-grade inflammation is a common feature of chronic kidney disease (CKD) that contributes to disease progression and mortality by leading to the retention of pro-inflammatory molecules in the blood.
Untreated chronic inflammation generally carries a poor prognosis.
Chronic inflammation involves the production of inflammatory cytokines, growth factors, and enzymes, which contribute to tissue damage progression and secondary repair processes such as fibrosis and granuloma formation.
The management of chronic inflammation requires an interprofessional team consisting of primary care physicians, nurses, physical therapists, dieticians, and specialists to address the underlying etiology and prevent complications.
Weight loss is the most effective lifestyle change for reducing chronic inflammation.
Diagnostic and imaging studies, such as colonoscopy for suspected inflammatory bowel disease, can assist in diagnosing conditions associated with chronic inflammation.
Chronic inflammation is associated with symptoms including body pain, arthralgia, myalgia, chronic fatigue, insomnia, depression, anxiety, mood disorders, gastrointestinal complications (such as constipation, diarrhea, and acid reflux), weight fluctuations, and frequent infections.
In genetically susceptible individuals, environmental factors such as smoking and infections induce chronic inflammation, leading to a systemic autoimmune response that causes local joint inflammation, immune cell infiltration, and cytokine release.
The hallmarks of chronic inflammation include the infiltration of primary inflammatory cells—specifically macrophages, lymphocytes, and plasma cells—into the tissue site, where they produce inflammatory cytokines, growth factors, and enzymes that contribute to tissue damage and secondary repair processes like fibrosis and granuloma formation.
Chronic inflammation is considered a major contributor to most chronic diseases and presents a significant threat to individual health and longevity.
Chronic inflammation can result from the failure to eliminate the agent causing acute inflammation, such as infectious organisms like Mycobacterium tuberculosis, protozoa, fungi, and other parasites that resist host defenses and persist in tissue.
Metformin is used to treat type II diabetic patients with dyslipidemia and low-grade inflammation, and it reduces circulating TNF-alpha, IL-1beta, CRP, and fibrinogen.